Market Cap 132.23M
Revenue (ttm) 0.00
Net Income (ttm) -27.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 15,900
Avg Vol 31,100
Day's Range N/A - N/A
Shares Out 19.53M
Stochastic %K 36%
Beta N/A
Analysts Strong Sell
Price Target $20.00

Latest News on ACTU

Cancer biotech Actuate Therapeutics files for a $50 million IPO

May 24, 2024, 5:28 PM EDT - 11 months ago

Cancer biotech Actuate Therapeutics files for a $50 million IPO


Actuate Therapeutics IPO Registration Document (S-1)

May 24, 2024, 4:59 PM EDT - 11 months ago

Actuate Therapeutics IPO Registration Document (S-1)